Paper218111
T antigen is bound to a host protein in SV40-transformed cells.
Lane DP and 1 other. Nature, 1979. Cited by 2,282 papers, by iCite.
Cite this record
ConductScience Library. T antigen is bound to a host protein in SV40-transformed cells. Papers, record 218111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/218111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Antigens, Viral | Major topic |
| Cell Transformation, Viral | Major topic |
| Proteins | Major topic |
| Simian virus 40 | Major topic |
| Cell Line | |
| Protein Binding | |
| Viral Proteins |
Source PubMed
Cited by904
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,282 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42965403 | Quantitative Multiplexed Rapid Immunoprecipitation and Mass Spectrometry of Endogenous Proteins (qPLEX-RIME) in Cell Lines. | Curr Protoc | 2026 | https://conductscience.org/library/papers/42965403 | PubMed |
| 42798018 | p53 in Canine Mammary Tumors: From Molecular Pathogenesis to Biomarker Applications and Comparative Oncology. | Vet Sci | 2026 | https://conductscience.org/library/papers/42798018 | PubMed |
| 42720426 | Establishment of Stable Immortalized Human Choroidal Melanocytes for Ocular Research. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42720426 | PubMed |
| 42663787 | Unveiling the role of p53 in the pathogenesis and treatment of autoimmune rheumatic diseases. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42663787 | PubMed |
| 42657381 | Diagnostic value and prognostic effect of has-miR-151a-3p in tuberculosis. | J Res Med Sci | 2026 | https://conductscience.org/library/papers/42657381 | PubMed |
| 42589374 | Proteomic Analysis of TCGA Data Reveals Limited Prognostic Value of p53 but Suggests BAX as a Potential Survival Marker in Cervical Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589374 | PubMed |
| 42457681 | Oncogene inactivation-induced senescence facilitates tumor relapse. | Nat Commun | 2026 | https://conductscience.org/library/papers/42457681 | PubMed |
| 42259916 | Targeting cancer-specific mutations with RNA-triggered chromatin shredding. | Nature | 2026 | https://conductscience.org/library/papers/42259916 | PubMed |
| 42238008 | Targeting non-small cell lung cancer: Molecular mechanisms and clinical studies (Review). | Oncol Lett | 2026 | https://conductscience.org/library/papers/42238008 | PubMed |
| 42146678 | Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin Shredding. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146678 | PubMed |
| 42063728 | Learning from plants: is it possible to make an animal organism a non-host for cancer? | Front Oncol | 2026 | https://conductscience.org/library/papers/42063728 | PubMed |
| 41939253 | Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation. | Hemasphere | 2026 | https://conductscience.org/library/papers/41939253 | PubMed |
| 41836060 | Mutant p53 and TP53 mutations in esophageal squamous cell carcinoma: consistency and diagnostic significance. | Front Genet | 2026 | https://conductscience.org/library/papers/41836060 | PubMed |
| 41799791 | Structural potential of the 5' noncoding regions of the mRNAs encoding p53 isoforms. | Acta Biochim Pol | 2026 | https://conductscience.org/library/papers/41799791 | PubMed |
| 41727427 | The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/41727427 | PubMed |
| 41593642 | New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/41593642 | PubMed |
| 41552434 | Restoration of the Y220C p53 Full-Length Mutant by PK11000: a Molecular Dynamics Study of an Intrinsically Disordered Protein. | ACS Omega | 2026 | https://conductscience.org/library/papers/41552434 | PubMed |
| 41305399 | Can Oncogenic Animal Viruses Pose a Threat to Humans? | Pathogens | 2025 | https://conductscience.org/library/papers/41305399 | PubMed |
| 41256339 | Rethinking p16, p53, and HPV in HNCSCC through lessons from glioblastoma subclonal evolution toward patient-centric N-of-1 single-cell RNA sequencing paradigm. | World J Clin Cases | 2025 | https://conductscience.org/library/papers/41256339 | PubMed |
| 41090915 | Deceiving the gatekeepers: virus modulation of gap junctions. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/41090915 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/218111
GET https://conductscience.org/api/papers/v1/218111/cited_by?page=2